AIDS Healthcare Foundation   Report issue

Foundation Phase 2 Phase 3
Founded: Los Angeles CA United States (1987)

Organization Overview

First Clinical Trial
2010
NCT01184456
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

AHF | AIDS Healthcare Foundation | AIDS Helthcare Foundation

Active Ingredients

Drugs in Phase 3 Trials (2)

benzathine penicillin (2 trials)

cefixime (suprax) (2 trials)

Drugs in Phase 2 Trials (3)

ephb4-hsa fusion protein (1 trial)

ganedenbc30 (1 trial)

mesalamine (rowasa) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 2)

HIV Infections (Phase 2)

Infections (Phase 2)

Inflammation (Phase 2)

Sarcoma (Phase 2)

Sarcoma, Kaposi (Phase 2)

Syphilis (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 5